New grad roles at Tr1X
Tr1X is a clinical-stage biotechnology company developing engineered Type 1 regulatory T-cell therapies for autoimmune, inflammatory, and transplant-related diseases. Its pipeline includes off-the-shelf allogeneic Tr1 and CAR-Tr1 therapies designed to restore immune tolerance.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Stage
- Series A
- Open roles
- 3
No current roles
Check back soon.
Get new Tr1X new grad roles by email
Free account. Get new Tr1X new grad roles by email or push the minute they post.
.png){kind=small}
